This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Feb;38(2):75-82.

doi: 10.1007/BF01526201.

Idiotypic antibody immunotherapy of cancer

M B Chatterjee¹, K A Foon, H Köhler

Affiliations

PMID: 8306369
PMCID: PMC11038353
DOI: 10.1007/BF01526201

Review

Idiotypic antibody immunotherapy of cancer

M B Chatterjee et al. Cancer Immunol Immunother. 1994 Feb.

. 1994 Feb;38(2):75-82.

doi: 10.1007/BF01526201.

Authors

M B Chatterjee¹, K A Foon, H Köhler

Affiliation

¹ Department of Microbiology and Immunology, University of Kentucky Medical Center, Lexington 40536.

PMID: 8306369
PMCID: PMC11038353
DOI: 10.1007/BF01526201

No abstract available

PubMed Disclaimer

Similar articles

Anti-idiotype antibody vaccine therapies of cancer.
Bhattacharya-Chatterjee M, Foon KA. Bhattacharya-Chatterjee M, et al. Cancer Treat Res. 1998;94:51-68. doi: 10.1007/978-1-4615-6189-7_4. Cancer Treat Res. 1998. PMID: 9587682 Review. No abstract available.
Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP, Lemoine NR, Wadhwa M, Thomas H, Snary D, Kmiot WA. Zbar AP, et al. Br J Cancer. 1998 Mar;77(5):683-93. doi: 10.1038/bjc.1998.114. Br J Cancer. 1998. PMID: 9514045 Free PMC article. Review. No abstract available.
Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.
Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. Campbell MJ, et al. Int Rev Immunol. 1989;4(4):251-70. doi: 10.3109/08830188909044782. Int Rev Immunol. 1989. PMID: 2519929 Review. No abstract available.
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Bhattachary-Chatterjee M, Nath Baral R, Chatterjee SK, Das R, Zeytin H, Chakraborty M, Foon KA. Bhattachary-Chatterjee M, et al. Cancer Immunol Immunother. 2000 Jun;49(3):133-41. doi: 10.1007/s002620050612. Cancer Immunol Immunother. 2000. PMID: 10881692 Free PMC article. Review.
[Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
Castello G, D'Alessio V. Castello G, et al. Clin Ter. 1991 May 15;137(3):155-67. Clin Ter. 1991. PMID: 1831084 Review. Italian.

See all similar articles

Cited by

Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.
Chan GC, Chan CM. Chan GC, et al. Biomolecules. 2022 Feb 24;12(3):358. doi: 10.3390/biom12030358. Biomolecules. 2022. PMID: 35327550 Free PMC article. Review.
Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain.
Kılıç G, Demirkan E, Yücel F. Kılıç G, et al. Mol Biotechnol. 2025 Apr;67(4):1556-1564. doi: 10.1007/s12033-024-01138-1. Epub 2024 Apr 25. Mol Biotechnol. 2025. PMID: 38662257 Free PMC article.
Anti-GD2 Strategy in the Treatment of Neuroblastoma.
Yang RK, Sondel PM. Yang RK, et al. Drugs Future. 2010;35(8):665. doi: 10.1358/dof.2010.035.08.1513490. Drugs Future. 2010. PMID: 21037966 Free PMC article.
Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma.
Bier H, Reiffen KA, Haas I, Stasiecki P. Bier H, et al. Eur Arch Otorhinolaryngol. 1995;252(7):433-9. doi: 10.1007/BF00167315. Eur Arch Otorhinolaryngol. 1995. PMID: 8562040 Clinical Trial.

References

1. Köhler H, Bona C. Idiotype therapy of tumors. Int Rev Immunol. 1989;4:251–260. - PubMed
1. Bhattacharya-Chatterjee M, Foon KA, Köhler H. Antiidiotype approaches to cancer therapy. Contemp Oncol. 1992;2:27.
1. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373. - PubMed
1. Nisonoff A, Lamoyi E. Implications of the presence of an internal image of the antigen anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol. 1981;21:397. - PubMed
1. Roitt IM, Cooke A, Male DK, Hay FC, Guarnotta G, Lydyard PM, Carvahlo KP, Thanalava Y, Ivanyi J. Idiotypic networks and their possible exploitation for manipulation of the immune respons. Lancet. 1981;1:1041. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- The Lens - Patent Citations Database